Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity-Reference-Cited by-全球学者库

Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity

Published:2023-07 Issue: Volume:41 Page:100902
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Fitzel Rahel,Secker-Grob Kathy-Ann,Keppeler Hildegard^ORCID,Korkmaz Fulya,Schairer Rebekka,Erkner Estelle,Schneidawind Dominik,Lengerke Claudia,Hentrich Thomas^ORCID,Schulze-Hentrich Julia M.^ORCID,Schneidawind Corina^ORCID

Publisher

Elsevier BV

Subject

Cancer Research

Reference36 articles.

1. Chromosomal translocations in cancer;Nambiar;Biochim. Biophys. Acta,2008

2. The MLL recombinome of acute leukemias in 2017;Meyer;Leukemia,2018

3. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation;Gaussmann;Oncogene,2007

4. Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents;Livio;Acta Biomed.,2018

5. Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9;Secker;Oncogene,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think;Journal of Clinical Medicine;2024-01-03

2. Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia;International Journal of Molecular Sciences;2023-09-23

3. The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth;Cancers;2023-07-28